Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Cirrhosis

Free Subscription Articles published in Intern Med Retrieve available abstracts of 35 articles: HTML format

Single Articles

February 2024
1. HADANO Y
   Use of Blood Culture Bottles in the Diagnosis of Spontaneous Bacterial Peritonitis.
   Intern Med. 2024;63:465.
   PubMed    
   
   
   October 2023
2. MIYAZAWA M, Yanagi M, Chiba T, Kido H, et al
   Post-allogeneic Hematopoietic Stem Cell Transplantation Portal Hypertension Not Associated with Liver Cirrhosis, Veno-occlusive Disease, or Graft-versus-host Disease: A Case Report.
   Intern Med. 2023 Oct 13. doi: 10.2169/internalmedicine.2489.
   PubMed     Abstract available
   
   
   May 2023
3. MITA E, Liu LJ, Shing D, Force L, et al
   Real-world Safety and Effectiveness of 24-week Sofosbuvir and Ribavirin Treatment in Patients Infected with Rare Chronic Hepatitis C Virus Genotypes 3, 4, 5, or 6 in Japan.
   Intern Med. 2023;62:1405-1414.
   PubMed     Abstract available
   
   
   April 2023
4. HAYAKAWA Y, Tamaki N, Nakanishi H, Kurosaki M, et al
   Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
   Intern Med. 2023;62:973-978.
   PubMed     Abstract available
   
   
   March 2023
5. KAINAGA M, Sasaki T, Kitamura M, Nakayama T, et al
   Inflammatory Myopathy Associated with Anti-mitochondrial Antibody-negative Primary Biliary Cholangitis Diagnosed by a Liver Biopsy.
   Intern Med. 2023;62:797-802.
   PubMed     Abstract available
   
   
   January 2023
6. SAITO S, Ueno N, Kamikokura Y, Sugiyama Y, et al
   Gastro-colic Fistula-associated Hypersplenism Causes Pancytopenia in a Patient with Crohn's Disease.
   Intern Med. 2023;62:69-74.
   PubMed     Abstract available
   
   
   October 2022
7. SUZUKI H, Sano T, Shimasaki Y, Yamaguchi M, et al
   TAFRO Syndrome That Responded to Prednisolone-only Treatment: Evaluating Changes in IL-6.
   Intern Med. 2022;61:2967-2972.
   PubMed     Abstract available
   
   
   September 2022
8. FUKUSHIMA M, Miyaaki H, Sasaki R, Haraguchi M, et al
   Most Cases of Cryptogenic Cirrhosis May be Nonobese Nonalcoholic Steatohepatitis-Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study.
   Intern Med. 2022 Sep 28. doi: 10.2169/internalmedicine.0514.
   PubMed     Abstract available
   
   
   June 2022
9. KASHIWAGI Y, Yoshida J, Nagoshi T, Hoshino S, et al
   Constrictive Pericarditis with Cardiac Ascites Caused Spontaneous Bacterial Peritonitis.
   Intern Med. 2022;61:1857-1861.
   PubMed     Abstract available
   
   
   May 2022
10. HYUN SUNG J, Sakamori R, Yamada R, Yoshioka T, et al
    Hepatocellular Carcinoma in a Patient with Tetralogy of Fallot: A Case Report and Literature Review.
    Intern Med. 2022;61:1361-1365.
    PubMed     Abstract available
    
    
    March 2022
11. NISHIMURA T, Ishikawa T, Kawamoto D, Sasaki R, et al
    A Case of Drastic Improvement in Hepatitis B/C Virus-induced Decompensated Liver Cirrhosis Treated by Total Management Consisting of Interventional Radiology, Endoscopy, and Pharmacotherapy.
    Intern Med. 2022 Mar 26. doi: 10.2169/internalmedicine.9240.
    PubMed     Abstract available
    
    
    January 2022
12. NISHINO K, Kawanaka M, Manabe N, Suehiro M, et al
    Portal Hypertensive Gastropathy in Liver Cirrhosis: Prevalence, Natural History, and Risk Factors.
    Intern Med. 2022;61:605-613.
    PubMed     Abstract available
    
    
    
13. FURUICHI Y, Koyama Y, Abe M, Yoshimasu Y, et al
    Discrimination between Portal Hypertensive Gastropathy and Helicobacter pylori-related Gastritis.
    Intern Med. 2022;61:601-603.
    PubMed    
    
    
    September 2021
14. USAMI J
    Primary Biliary Cholangitis-associated Palmar Keratosis.
    Intern Med. 2021;60:2877.
    PubMed    
    
    
    June 2021
15. KOYAMA M, Yamazaki T, Joshita S, Ito A, et al
    An Autopsy Case of Primary Biliary Cholangitis with Histological Submassive Hepatic Necrosis Caused by Acute Hepatitis E Virus Infection.
    Intern Med. 2021;60:1863-1870.
    PubMed     Abstract available
    
    
    
16. HONMA Y, Shibata M, Gohda T, Matsumiya H, et al
    Rapid Progression of Liver Fibrosis Induced by Acute Liver Injury Due to Immune-related Adverse Events of Atezolizumab.
    Intern Med. 2021;60:1847-1853.
    PubMed     Abstract available
    
    
    May 2021
17. HAMAHATA A, Mitsusada S, Iwata T, Nakajima K, et al
    A Case of Liver Cirrhosis Complicated by Spontaneous Bacterial Peritonitis Caused by the Burkholderia cepacia complex.
    Intern Med. 2021 May 14. doi: 10.2169/internalmedicine.7170.
    PubMed     Abstract available
    
    
    
18. KOGAMI T, Uojima H, Ebato T, Bando Y, et al
    Cartilage-hair Hypoplasia Complicated with Liver Cirrhosis Due to Chronic Intrahepatic Cholestasis: A Case Report.
    Intern Med. 2021 May 7. doi: 10.2169/internalmedicine.7483.
    PubMed     Abstract available
    
    
    March 2021
19. SHIGEFUKU R, Iwasa M, Yoshikawa K, Takei Y, et al
    A Rare Presentation of Intraperitoneal Ectopic Varices Rupture.
    Intern Med. 2021;60:959-960.
    PubMed    
    
    
    
20. KATO S, Sakamori R, Yamada R, Murai K, et al
    The First Case of Coil Embolization for Left Gastric Vein Aneurysm with Liver Cirrhosis: A Case Report and Review of the Literature.
    Intern Med. 2021 Mar 8. doi: 10.2169/internalmedicine.6565.
    PubMed     Abstract available
    
    
    February 2021
21. TOTSUKA M, Honda M, Kanda T, Ishii T, et al
    Japanese Man with HCV Genotype 4 Infection and Cirrhosis Who was Successfully Treated by the Combination of Glecaprevir and Pibrentasvir.
    Intern Med. 2021 Feb 1. doi: 10.2169/internalmedicine.6728.
    PubMed     Abstract available
    
    
    January 2021
22. SAKAMORI R, Yamada R, Shinkai K, Doi A, et al
    Improvement of Skeletal Muscle Mass after Ledipasvir and Sofosbuvir Treatment for Hepatitis C Virus in Decompensated Liver Cirrhosis.
    Intern Med. 2021;60:745-750.
    PubMed     Abstract available
    
    
    
23. FUJIWARA Y, Suzuki K, Yusa K, Eizuka M, et al
    Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy.
    Intern Med. 2021;60:1027-1033.
    PubMed     Abstract available
    
    
    
24. YOKOKAWA T, Yoshihisa A, Misaka T, Sato T, et al
    Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.
    Intern Med. 2021;60:201-208.
    PubMed     Abstract available
    
    
    
25. SHIGEFUKU R, Iwasa M, Eguchi A, Tempaku M, et al
    Serum Copeptin and Zinc-alpha2-glycoprotein Levels Are Novel Biomarkers of Tolvaptan Treatment in Decompensated Cirrhotic Patients with Ascites.
    Intern Med. 2021;60:3359-3368.
    PubMed     Abstract available
    
    
    
26. ABE K, Fujita M, Hayashi M, Takahashi A, et al
    The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic Encephalopathy.
    Intern Med. 2021;60:3533-3542.
    PubMed     Abstract available
    
    
    December 2020
27. TATSUMI R, Suii H, Yamaguchi M, Arakawa T, et al
    Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis.
    Intern Med. 2020 Dec 22. doi: 10.2169/internalmedicine.6039.
    PubMed     Abstract available
    
    
    
28. ISHIKAWA T, Sasaki R, Nishimura T, Matsuda T, et al
    Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6267.
    PubMed     Abstract available
    
    
    
29. SHIMADA M, Hirashima N, Iwase H, Saito M, et al
    Evaluation of Muscle Cramp Associated with Liver Cirrhosis with a Focus on the Liver Function and Nutritional Status.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6231.
    PubMed     Abstract available
    
    
    
30. KAWANAKA M, Nishino K, Morimoto Y, Ishii K, et al
    Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years: A Case Report.
    Intern Med. 2020 Dec 7. doi: 10.2169/internalmedicine.6118.
    PubMed     Abstract available
    
    
    October 2020
31. NISHINO K, Kawanaka M, Suehiro M, Yoshioka N, et al
    Gastric Hyperplastic Polyps after Argon Plasma Coagulation for Gastric Antral Vascular Ectasia in Patients with Liver Cirrhosis - A Case Suggesting the "Gastrin Link Theory".
    Intern Med. 2020 Oct 28. doi: 10.2169/internalmedicine.5837.
    PubMed     Abstract available
    
    
    July 2020
32. SEIKE T, Komura T, Shimizu Y, Omura H, et al
    The Serum Mac-2-binding Protein Glycosylation Isomer Dynamics in Acute Liver Injury.
    Intern Med. 2020;59:1581-1588.
    PubMed     Abstract available
    
    
    April 2020
33. HARAGUCHI M, Hirai S, Nakamura Y, Otsuka T, et al
    Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation.
    Intern Med. 2020;59:1047-1051.
    PubMed     Abstract available
    
    
    
34. SAWADA K, Takai A, Yamada T, Araki O, et al
    Hepatitis-associated Aplastic Anemia with Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis.
    Intern Med. 2020;59:1035-1040.
    PubMed     Abstract available
    
    
    January 2020
35. ISHIKAWA T, Endo S, Imai M, Azumi M, et al
    Changes in the Body Composition and Nutritional Status after Long-term Rifaximin Therapy for Hyperammonemia in Japanese Patients with Hepatic Encephalopathy.
    Intern Med. 2020;59:2465-2469.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.